Article
Selection of optimal therapeutic modality for early-stage extranodal natural killer/T-cell lymphoma patients under the guidance of single-nucleotide polymorphism signature.
Bosnian journal of basic medical sciences - 1 Apr 2022
Chen Zhe-Sheng, Yang Dong-Hua
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
